Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

44 results about "Eisosome assembly" patented technology

The aggregation, arrangement and bonding together of a set of components to form an eisosome, a cell part that is composed of the eisosome membrane or MCC domain, a furrow-like plasma membrane sub-domain and associated integral transmembrane proteins, and the proteins (eisosome filaments) that form a scaffolding lattice on the cytoplasmic face. [GOC:al, GOC:jp, PMID:19564405]

Prodrug activation compound, prodrug system, preparation method and application thereof

ActiveCN111718395AProdrug activation achievedTo achieve specific enrichmentOrganic active ingredientsPeptide preparation methodsPhosphorylationTyrosine
The invention provides a prodrug activation compound, which is characterized by comprising a polypeptide fragment, and a tetrazine group and a hydrophobic group which are connected to the polypeptidefragment through chemical bonds; wherein at least one phosphorylated tyrosine exists in the amino acid of the polypeptide fragment. The prodrug activation compound provided by the invention has targeting property and specificity, can be quickly and efficiently accumulated in tumor cells and is self-assembled in situ to form a nano assembly, so that a trans-cyclooctene modified anti-tumor prodrug is efficiently and specifically activated; the prodrug activating compound and the prodrug system are good in biocompatibility and free of system toxicity. A solid-phase synthesis method is adopted inthe preparation method of the prodrug activated compound, the operation is simple, and the obtained product is high in chemical purity and high in total yield.
Owner:THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA

Expression vector of nuclease protein Cas9 and construction method and expression purification of expression vector of nuclease protein Cas9

The invention discloses an expression vector of a nuclease protein Cas9 and a construction method and expression purification of the expression vector of the nuclease protein Cas9. According to the expression vector of the nuclease protein Cas9, an original thioredoxin sequence in pET32a is replaced with cDNA of an amplified thioredoxin-histidine-tag-tobacco-etch-virus-protease recognition site, and codons are optimized to a Cas9 gene sequence which is easy to express in a host and has nuclear localization signal peptide and 3xFLAG tag sequence fused in a C-terminal to be integrated into the thioredox in sequence. According to the expression vector of the nuclease protein Cas9 and the construction method and expression purification of the expression vector of the nuclease protein Cas9, codon optimization and thioredoxin fusion expression are used for obtaining a large amount of the nuclease Cas9 protein, under the condition that only an LB medium is used, 10 mg of a highly purified active Cas9 protein can be finally obtained per gram of escherichia coli Tuner (DE3) wet bacteria, and high expression of the high-fidelity nuclease protein Cas9 at a low cost is realized; and the requirements on the host are not high, and the obtained protein can be used for large-scale biological in vitro assembly and in vivo gene editing experiments.
Owner:NANJING UNIV OF SCI & TECH

Biosensor as well as preparation method and application

The invention discloses a biosensor as well as a preparation method and application thereof. The biosensor disclosed by the invention is an assembly comprising gold and silver core-shell nanoparticle-tetrahedral structure DNA containing azobenzene molecules. The preparation method of the biosensor comprises the following steps of: preparing the gold and silver core-shell nanoparticles; preparing tetrahedral structure DNA containing the azobenzene molecules; and (3) assembling the gold and silver core-shell nanoparticle-tetrahedron DNA assembly containing the azobenzene molecules. According tothe biosensor which is the assembly comprising the gold and silver core-shell nanoparticle-tetrahedral structure DNA containing azobenzene molecules, high-sensitivity detection of miR-21 can be achieved on the single-nanoparticle scale, the concentration of miR-21 and the red shift amount of a scattering spectrum of the gold-silver core-shell nanoparticle-tetrahedral structure DNA assembly containing the azobenzene molecules are in a linear relation, and important significance is achieved for diagnosis and prognosis treatment of early-stage cancer.
Owner:NANJING UNIV OF POSTS & TELECOMM

Strong oncolytic rod-shaped nano-assembly, preparation method and application thereof

The present invention provides a strong oncolytic rod-shaped nano-assembly and a preparation method thereof. Oncolytic monomers of dendritic peptide molecules are constructed. The oncolytic monomers comprise chemotherapeutic drugs connected by sensitive bonds and residues peripherally modified with oncolytic effects, and the residues are covered with a negatively charged shielding layer; the oncolytic monomers are induced to self-assemble on inner cores and closely arranged on surfaces of the inner cores to form the rod-shaped nano-assembly; or the rod-shaped nano-assembly is directly stackedthrough an organic molecular design. The provided rod-shaped supramolecular assembly morphology affects biological behaviors of particles, has advantages of prolonging blood drug circulation time, increasing tumor enrichment, improving solid tumor penetration ability, increasing cell uptake and special subcellular organelle enrichment, etc., and greatly increases anti-tumor effects.
Owner:NANJING IND INST FOR ADVANCED INTELLIGENT EQUIP

LIPID ASSEMBLIES AND USES THEREOF AND SOME pH AND ELECTROSTATIC MODULATING LIPIDS TO BE USED IN SAID ASSEMBLIES

Provided are modified lipid compounds and their use in the formation of lipid assemblies. Also provided are lipid assemblies including (a) an amphoteric lipid including in covalent association with (i) one or more acyl chains; (ii) one or more weak base moiety; (iii) one or more weak acid moiety; the lipid assembly also including (b) one or more additional lipids, at least one of which being a zwitterionic lipid. In some embodiments, the amphoteric lipid is a compound including (a) a tri-functional moiety; (b) two non-phosphate lipid chains associated with two of the functional moieties of said tri-functional moiety; (c) optionally a spacer moiety associated with the third of the functional moieties of said tri-functional moiety; and (d) a polyalkylamine optionally including a short peptide with one to several carboxylic acid residues. Further provided are the uses of the lipid assembly, inter alia, for transfection or cancer treatment.
Owner:YISSUM RES DEV CO OF THE HEBREW UNIV OF JERUSALEM LTD

A nucleic acid delivery carrier and its preparation method and application

The invention provides a nucleic acid delivery carrier, a preparation method and application of the nucleic acid delivery carrier. The nucleic acid delivery carrier is a nanometer self-assembled bodyof an amphiphilic fluorinated material; and the amphiphilic fluorinated material is perfluorooctane-substituted oligomeric polyethyleneimine. According to the nucleic acid delivery carrier provided bythe invention, oligomeric polyethyleneimine and the perfluorooctane material are bonded together, and due to strong hydrophobicity of the perfluor material, not only can the nucleic acid compressingcapability of oligomeric polyethyleneimine be improved, but also the efficiency of cell endocytosis and endosome escape can be improved; positive charges of oligomeric polyethyleneimine not only can be used for electrostatic composition of siRNA, but also can utilize proton sponge effect to promote the endosome escape in the system, and by the combination of electrostatic composition of siRNA andthe endosome escape, the nucleic acid delivery carrier not only has very-high silence efficiency under the serum-free condition, but also can show very high nucleic acid delivery efficiency in the presence of serum, and is expected to be applied in gene therapy based on siRNA or DNA.
Owner:THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products